Jonathan Rubin, MD, serves as the Senior Vice President and Chief Medical Officer of Research and Development at Supernus Pharmaceuticals, Inc. Dr. Rubin is a seasoned medical professional with extensive experience in the pharmaceutical industry. He earned his medical degree from the University of Pennsylvania School of Medicine and completed his residency in internal medicine at the Hospital of the University of Pennsylvania. Dr. Rubin further honed his expertise through a fellowship in endocrinology, diabetes, and metabolism at the University of California, San Francisco. Throughout his career, Dr. Rubin has held several leadership positions in the pharmaceutical sector, contributing significantly to the development and approval of multiple novel therapies. Before joining Supernus Pharmaceuticals, he worked at major pharmaceutical companies such as Merck & Co., where he played a key role in the development of treatments for diabetes and cardiovascular diseases. His deep understanding of clinical development and regulatory affairs has been instrumental in bringing innovative treatments to market. At Supernus Pharmaceuticals, Dr. Rubin's role as Senior Vice President and Chief Medical Officer of Research and Development is pivotal. He oversees the company's clinical research programs, ensuring the advancement of their pipeline of central nervous system (CNS) therapies. Under his leadership, Supernus has successfully navigated the complex landscape of drug development, achieving several milestones in the treatment of epilepsy, ADHD, and other neurological disorders. Dr. Rubin's strategic vision and commitment to scientific excellence continue to drive Supernus Pharmaceuticals forward in its mission to improve the lives of patients with CNS disorders.